AUTONOMIX MEDICAL, INC. Stock-Based Compensation
AUTONOMIX MEDICAL, INC. (AMIX) reported Stock-Based Compensation of $2.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- AUTONOMIX MEDICAL, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.00K, a 99.48% decline year-over-year.
- AUTONOMIX MEDICAL, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.00K, a 99.94% decline year-over-year.
- AUTONOMIX MEDICAL, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.00K, a 99.52% decline year-over-year.
- AUTONOMIX MEDICAL, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $138.00K, a 68.99% decline year-over-year.
- AUTONOMIX MEDICAL, INC. share-based payment arrangement, noncash expense for fiscal 2026 was $529.00K, a 67.51% decline from fiscal 2025.
- AUTONOMIX MEDICAL, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $1.63M, a 163.43% increase from fiscal 2024.
- AUTONOMIX MEDICAL, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $618.00K.
- AUTONOMIX MEDICAL, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $0.00.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-13 | $3.00K derived: sum of 2 quarters · filed 2026-08-13 | $5.00K derived: sum of 3 quarters · filed 2026-08-13 | $143.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-27 | $3.00K derived: sum of 2 quarters · filed 2026-05-27 | $141.00K derived: sum of 3 quarters · filed 2026-05-27 | $529.00K 10-K · filed 2026-05-27 |
| 2025-12-31 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | $140.00K derived: sum of 2 quarters · filed 2026-02-11 | $528.00K 10-Q · filed 2026-02-11 | $2.16M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-12 | $526.00K 10-Q · filed 2025-11-12 | $2.15M derived: sum of 3 quarters · filed 2026-08-13 | $2.57M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $388.00K 10-Q · filed 2026-08-13 | $2.02M derived: sum of 2 quarters · filed 2026-08-13 | $2.43M derived: sum of 3 quarters · filed 2026-08-13 | $2.88M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.63M 10-K · filed 2025-05-29 | $2.05M derived: sum of 2 quarters · filed 2026-02-11 | $2.49M derived: sum of 3 quarters · filed 2026-02-11 | $1.63M 10-K · filed 2026-05-27 |
| 2024-12-31 | $418.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | $863.00K derived: sum of 2 quarters · filed 2026-02-11 | $1.22M 10-Q · filed 2026-02-11 | $1.84M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | $445.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-12 | $805.00K 10-Q · filed 2025-11-12 | $1.42M derived: sum of 3 quarters · filed 2025-11-12 | $1.64M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $360.00K 10-Q · filed 2025-08-13 | $978.00K derived: sum of 2 quarters · filed 2025-08-13 | $1.19M derived: sum of 3 quarters · filed 2025-08-13 | $1.34M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $618.00K 10-K · filed 2025-05-29 | $830.00K derived: sum of 2 quarters · filed 2025-05-29 | $981.00K derived: sum of 3 quarters · filed 2025-05-29 | $618.00K 10-K · filed 2024-05-31 |
| 2023-12-31 | $212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $363.00K derived: sum of 2 quarters · filed 2025-02-13 | $363.00K 10-Q · filed 2025-02-13 | $363.00K derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-08 | $151.00K 10-Q · filed 2024-11-08 | $151.00K derived: sum of 3 quarters · filed 2024-11-08 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-13 | $0.00 derived: sum of 2 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-31 | $0.00 10-K · filed 2024-05-31 | ||
| 2022-12-31 | $0.00 10-Q · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |